Suppr超能文献

了解丙型肝炎的个人健康状况及后果评估,尚不足以改变瑞典斯德哥尔摩郡注射吸毒者的危险行为。

Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.

作者信息

Norden Lillebil, Saxon Lars, Kåberg Martin, Käll Kerstin, Franck Johan, Lidman Christer

机构信息

Department of Clinical Neuroscience, Karolinska Institutet, Huddinge, Stockholm, Sweden.

出版信息

Scand J Infect Dis. 2009;41(10):727-34. doi: 10.1080/00365540903159279.

Abstract

This was a multicentre study with risk perception as the theoretical framework, investigating if risk behaviours change when injecting drug users (IDUs) are aware of their hepatitis C virus (HCV) status and had assessed the health consequences with HCV infection. Two hundred and thirteen participants aged 15-40 y were analysed. Sharing of needles and of other injecting equipment were common both among participants who reported HCV-positive status (74%, 95% confidence interval (CI) 65.3-80.1%) and among those who reported HCV status unknown (68%, 95% CI 56.0-78.4%). Participants associating very severe health consequences with HCV infection and those who did not know of any health consequences with HCV infection shared needles at almost the same rate (78%, 95% CI 62.5-87.7 vs 69%, 95% CI 8.0-78.9, respectively). Sharing of other injecting equipment was most common among participants with verified HCV-positive status (adjusted risk ratio 5.64, 95% CI 2.64-12.07). Knowledge of HCV status and assessment of health consequences with HCV infection were not enough to change injecting risk behaviours. Sharing of other injecting equipment was a more important risk factor than sharing needles for participants with verified HCV-positive status. It is suggested that professionals engage IDUs in risk analysis and open a dialogue about assessment in order to identify, quantify and characterize risks.

摘要

这是一项以风险认知为理论框架的多中心研究,旨在调查注射吸毒者(IDU)知晓自身丙型肝炎病毒(HCV)感染状况并评估HCV感染对健康的影响后,其风险行为是否会发生改变。对213名年龄在15至40岁的参与者进行了分析。在报告HCV检测呈阳性的参与者中(74%,95%置信区间(CI)65.3 - 80.1%)以及报告HCV感染状况未知的参与者中(68%,95% CI 56.0 - 78.4%),共用针头和其他注射器具的情况都很常见。将HCV感染与极其严重的健康后果联系起来的参与者以及那些不知道HCV感染会造成任何健康后果的参与者共用针头的比例几乎相同(分别为78%,95% CI 62.5 - 87.7和69%,95% CI 8.0 - 78.9)。在经证实HCV检测呈阳性的参与者中,共用其他注射器具的情况最为常见(调整风险比5.64,95% CI 2.64 - 12.07)。知晓HCV感染状况以及评估HCV感染对健康的影响不足以改变注射风险行为。对于经证实HCV检测呈阳性的参与者而言,共用其他注射器具比共用针头是更重要的风险因素。建议专业人员让注射吸毒者参与风险分析并开启关于评估的对话,以便识别、量化和描述风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验